跳至主要内容
临床试验/NCT02804100
NCT02804100Unknown不适用

A Multi-centre Observational Study on Dynamic Changes of Circulating Tumor DNA in Late Stage NSCLC Patients Under Gefitinib Treatment

Wenzhou Medical University1 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2016年5月最近更新:
适应症

试验速览

阶段
不适用
入组人数
200
试验地点
1
主要终点
dynamic changes of circulating tumor DNA in late stage NSCLC patients under Gefitinib treatment

研究概览

简要总结

A multi-centre observational, non-interventional study is to dynamically monitor the changes of circulating tumor DNA (ctDNA) in late stage NSCLC patients under Gefitinib treatment.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Provision of informed consent
  • Histologically confirmed stage IIIB/IV NSCLC.
  • Activating EGFR mutations (G719A/C/S; Exon 19 insertion/deletion; L858R; L861Q)
  • Able to comply with the required protocol and followed-up procedures, and able to receive oral medications

排除标准

  • Histologically confirmed small cell lung cancer or other metastatic tumors
  • Patient had received prior chemotherapy or EGFR-TKIs treatment
  • Patients who harbor Exon20 T790M mutation

结局指标

主要结局

dynamic changes of circulating tumor DNA in late stage NSCLC patients under Gefitinib treatment

时间窗: 2 years

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Chunming Ding

Professor

Wenzhou Medical University

研究点 (1)

Loading locations...

相似试验